FDMT Pfcf Ratio from 2010 to 2024

FDMT Stock  USD 7.50  0.12  1.57%   
4D Molecular PFCF Ratio yearly trend continues to be comparatively stable with very little volatility. PFCF Ratio is likely to outpace its year average in 2024. From the period from 2010 to 2024, 4D Molecular PFCF Ratio quarterly data regression had mean square error of  843.37 and mean deviation of  47.09. View All Fundamentals
 
PFCF Ratio  
First Reported
2010-12-31
Previous Quarter
(10.09)
Current Value
(9.59)
Quarterly Volatility
49.26546108
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 4D Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4D Molecular's main balance sheet or income statement drivers, such as Net Interest Income of 9.6 M, Interest Income of 9.6 M or Depreciation And Amortization of 4.2 M, as well as many indicators such as Price To Sales Ratio of 36.34, Dividend Yield of 0.0 or PTB Ratio of 2.7. FDMT financial statements analysis is a perfect complement when working with 4D Molecular Valuation or Volatility modules.
  
Check out the analysis of 4D Molecular Correlation against competitors.

Latest 4D Molecular's Pfcf Ratio Growth Pattern

Below is the plot of the Pfcf Ratio of 4D Molecular Therapeutics over the last few years. It is 4D Molecular's PFCF Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 4D Molecular's overall financial position and show how it may be relating to other accounts over time.
Pfcf Ratio10 Years Trend
Slightly volatile
   Pfcf Ratio   
       Timeline  

FDMT Pfcf Ratio Regression Statistics

Arithmetic Mean34.25
Coefficient Of Variation143.83
Mean Deviation47.09
Median78.40
Standard Deviation49.27
Sample Variance2,427
Range109
R-Value(0.82)
Mean Square Error843.37
R-Squared0.68
Significance0.0002
Slope(9.07)
Total Sum of Squares33,979

FDMT Pfcf Ratio History

2024 -9.59
2023 -10.09
2022 -7.32
2021 -7.78
2020 -21.31
2019 -26.88
2018 -30.42

About 4D Molecular Financial Statements

4D Molecular shareholders use historical fundamental indicators, such as Pfcf Ratio, to determine how well the company is positioned to perform in the future. Although 4D Molecular investors may analyze each financial statement separately, they are all interrelated. The changes in 4D Molecular's assets and liabilities, for example, are also reflected in the revenues and expenses on on 4D Molecular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
PFCF Ratio(10.09)(9.59)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for FDMT Stock Analysis

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.